1. "We are still doing some magic": Exploring the effectiveness of online therapeutic clowning. Issue 2 (4th May 2023) Authors: Holland, Melissa; Fiorito, Maria-Elena; Gravel, Maï-Li; McLeod, Sarah; Polson, Jenna; Incio-Serra, Natalia; Blain-Moraes, Stefanie Journal: Arts & health Issue: Volume 15:Issue 2(2023) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1254. In vitro activity of sulbactam-durlobactam against recent global clinical Acinetobacter baumannii-calcoaceticus complex isolates. (31st December 2020) Authors: McLeod, Sarah; Moussa, Samir; Hackel, Meredith; Miller, Alita Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S644 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1293. Sulbactam-durlobactam is active against recent, multi-drug resistant Acinetobacter baumannii clinical isolates from the Middle East. (31st December 2020) Authors: Miller, Alita; McLeod, Sarah; Moussa, Samir; Hackel, Meredith Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 225. Efficacy and safety of sulbactam-durlobactam are consistent across regions in the global ATTACK phase 3 trial in the treatment of carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRABC) infections. (15th December 2022) Authors: Miller, Alita; Shapiro, Adam B; McLeod, Sarah; Rana, Khurram; Lewis, Drew; Altarac, David Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 518. Characterization of colistin-resistant (COL-R) Acinetobacter baumannii calcoaceticus complex (ABC) isolates from a recent, global Phase 3 trial (ATTACK). (15th December 2022) Authors: Moussa, Samir; McLeod, Sarah; Miller, Alita Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 732. Microbiologic and clinical outcome concordance in the global phase 3 ATTACK trial: Sulbactam-durlobactam (SUL-DUR) versus colistin therapy in patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections. (15th December 2022) Authors: Altarac, David; Miller, Alita; McLeod, Sarah; Shapiro, Adam B; Rana, Khurram; Lewis, Drew; Poirier, Gabrielle; Chabas, Daria Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 734. Efficacy of sulbactam-durlobactam (SUL-DUR) versus colistin in patients with extensively drug-resistant (XDR) and pan-drug resistant (PDR) Acinetobacter baumannii-calcoaceticus complex (ABC) infections. (15th December 2022) Authors: Miller, Alita; McLeod, Sarah; Shapiro, Adam B; Rana, Khurram; Lewis, Drew; Poirier, Gabrielle; Chabas, Daria; Altarac, David Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical outcomes in a high nursing ratio ward setting for children with obstructive sleep apnea at high risk after adenotonsillectomy. (March 2016) Authors: Arachchi, Sarah; Armstrong, David S.; Roberts, Noel; Baxter, Malcolm; McLeod, Sarah; Davey, Margot J.; Nixon, Gillian M. Journal: International journal of pediatric otorhinolaryngology Issue: Volume 82(2016:Mar.) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baumannii-calcoaceticus Complex (ABC) Infections. (15th December 2022) Authors: Bhavnani, Sujata M; Bhavnani, Sujata M; Bhavnani, Sujata M; Rubino, Christopher M; Hammel, Jeffrey P; Cammarata, Anthony P; Larson, Kajal; Liolios, Kathryn; McLeod, Sarah; Miller, Alita; Ambrose, Paul G; Tommasi, Ruben; O'Donnell, John Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real‐Time Monitoring of New Delhi Metallo‐β‐Lactamase Activity in Living Bacterial Cells by 1H NMR Spectroscopy1. (22nd January 2014) Authors: Ma, Junhe; McLeod, Sarah; MacCormack, Kathleen; Sriram, Shubha; Gao, Ning; Breeze, Alexander L.; Hu, Jun Journal: Angewandte Chemie Issue: Volume 126:Number 8(2014) Page Start: 2162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗